JASCAYD is the first and only preferential PDE4B inhibitor approved for IPF, offering a novel mechanism of action with both antifibrotic and immunomodulatory effects to help slow lung function decline in patients living with this debilitating disease
Most are mild, often linked to how the medication affects your stomach and appetite, and improve over time, particularly after the early weeks of treatment or dose increases
"It helps restore your metabolism and is one of the strongest predictors of maintaining weight loss, whether someone stays on a GLP-1 or not." Check in with yourself Losing weight, no matter how much, can have lasting effects on your mental health, confidence, relationships and emotional state
@_@ *rolls eyes* Anyway, it's my fault because I got excited after seeing that it's already available in Watsons